首頁 > 市場調查報告書 > 醫療設備

生技設備拋棄式

市場調查報告書

商品編碼

2059308

一次性組件市場：市場洞察、競爭格局與市場預測（2034 年）

Single-use Assemblies - Market Insights, Competitive Landscape, and Market Forecast - 2034

出版日期: 2026年05月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

一次性組件市場概述

全球一次性組件市場規模預計將從 2025 年的 137.6295 億美元成長到 2034 年的 481.7343 億美元，顯示市場將保持強勁且持續的成長。
全球一次性組件市場預計在 2026 年至 2034 年的預測期內將以 15.05% 的複合年成長率成長。
生物製藥和生物製劑的快速成長、對靈活模組化生產日益成長的需求，以及細胞和基因治療生產的擴張，共同推動了生物製程產業對一次性組件的加速應用。隨著生物製藥產品線的擴展，製造商需要擴充性、無污染且經濟高效的生產系統，而一次性組件恰好能夠滿足這些需求。同時，模組化設施的普及使得設備能夠更快地完成設置、實現多產品生產並降低操作複雜性，進一步增強了對一次性系統的依賴。此外，細胞和基因治療的複雜性和小批量生產的特點，要求高度可控的密封系統環境，而一次性組件在確保無菌性、降低交叉污染風險以及支持快速製程開發方面發揮著至關重要的作用。這些趨勢共同推動了市場強勁且永續的成長。
在一次性組件市場中營運的主要公司包括 Thermo Fisher Scientific Inc.、Sartorius AG、Cytiva（丹納赫公司）、Merck KGaA、Avantor, Inc.、Corning Incorporated、Saint-Gobain Life Sciences、Repligen Corporation、Meissner Filtration Products, Inc.、Enteral, Inc.、Enteral Corporation、Petal Corporation、Ptech接ex Corporation、Ent.Ptech） AG、Lonza Group AG、ABEC, Inc.、3M、Parker-Hannifin Corporation 和 Colder Products Company (CPC)。
由於北美地區擁有眾多大型生物製藥企業、先進的生物製藥生產基礎設施，以及一次性技術在商業和臨床規模生產中的高普及率，預計該地區將主導一次性組裝市場。此外，該地區在細胞和基因治療、疫苗研發以及單株抗體生產方面的大量投資也為其發展提供了有利條件，這些領域高度依賴靈活且無污染的生物製程系統。同時，賽默飛世爾科技公司、Cytiva公司和默克公司等主要市場參與企業的強勢地位，以及完善的合約研發生產（CDMO）生態系統和支持性的法規結構，進一步鞏固了北美在該市場的領先地位。
在一次性組件市場產品細分領域中，預計到 2025 年，過濾組件類別將佔最大的市場佔有率。

推動一次性組裝市場成長的因素

生物製藥的快速成長和一次性組件需求的激增：包括單株抗體、重組蛋白、疫苗和生物相似藥在內的生物製藥的擴張是推動一次性組件發展的主要動力。這些治療方法需要柔軟性、擴充性且污染可控的生產系統，而一次性技術恰好能夠滿足這些需求。全球對生物製藥日益成長的需求正在加速其在商業和臨床生產中的應用。
對靈活模組化生產的需求日益成長：製藥公司和合約研發生產機構（CDMO）正從大型固定式不銹鋼生產廠房轉向模組化和靈活的生產設施。在這一轉型過程中，一次性組件發揮著至關重要的作用，它們能夠實現不同生產批次之間的快速切換，允許在同一設施內生產多種產品，並顯著減少設施的整體面積和基礎設施的複雜性。這種柔軟性對於小批量生物製藥和個人化藥物的生產尤其重要，因為這類生產必須敏捷且高效、可擴展，並且需要快速回應高度特定的患者或產品需求。
拓展細胞和基因治療生產：細胞療法、基因療法和再生醫學需要高度專業化的生產條件，包括小規模、嚴格控制的環境、密封的無菌處理系統以及應對顯著產品差異的能力。一次性組件能夠維持無菌狀態、降低污染風險，並提供複雜、患者特異性流程所需的柔軟性，從而完美滿足這些要求。因此，它們已成為先進生物製造工作流程中不可或缺的組成部分，例如 CAR-T 細胞療法、病毒載體生產和幹細胞生產。

一次性組件市場細分報告

本一次性組件市場報告全面概述了全球一次性組件市場，揭示了關鍵趨勢、成長要素、挑戰和機會。報告涵蓋了詳細的市場細分，包括產品（袋式組件、過濾組件、瓶式組件、混合系統組件、管路和連接器組件）、解決方案（標準和客製化）、應用（上游工程、下游製程、過濾、取樣和流體處理、填充和精加工/滅菌）、材料類型（聚乙烯 (PE)、聚氯乙烯(PP)、新製藥公司 (PPC) 及其生物生產技術公司 (PPC）及其他）以及地區。報告深入分析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。報告詳細介紹了主要行業參與企業和近期產品創新，為企業提供關鍵數據，以識別市場潛力、制定戰略計劃並把握快速成長的一次性組件市場中的新興機會。

一次性組件是一種預先滅菌的、一次性使用的系統，由相互連接的組件（例如袋子、管道、過濾器和連接器）組成，用於生物製藥生產中液體的處理、加工和儲存。它在使用一次後即被丟棄，以降低污染風險並提高操作柔軟性。

生物製藥產業的快速發展以及對靈活模組化生產解決方案日益成長的需求，正顯著推動一次性組件在整個生物製程產業的應用。隨著生物製藥產品線規模和複雜性的不斷擴大，製造商面臨擴充性、無污染且經濟高效的生產系統，並能快速適應不斷變化的生產需求。一次性組件透過省去大規模的清潔和滅菌流程，同時減少批次間的停機時間，滿足了這些要求。

同時，整個產業向模組化、多產品生產設施的轉型進一步推動了一次性系統的應用。這些設施具有安裝速度更快、驗證更簡便、以及能夠在最大限度減少營運中斷的情況下切換不同產品等優勢，使得一次性系統在現代生物製造環境中成為極具優勢的選擇。此外，以小批量、高價值和高度個人化治療為特徵的細胞和基因治療生產的快速擴張，也增加了對封閉式、高度可控的加工環境的需求。一次性組件尤其適用於這些應用，因為它們能夠確保無菌性、最大限度地降低交叉污染的風險，並支援加速製程開發和規模化生產。這些因素共同推動了全球一次性組件市場的強勁持續成長。

一次性組裝市場的最新市場動態和趨勢是什麼？

生物製藥產業的快速成長是推動一次性組件加速普及的主要動力。這些治療藥物，例如單株抗體、疫苗和重組蛋白，需要高度無菌、可擴展且無污染的生產環境。一次性系統無需清洗和驗證流程，顯著減少了停機時間，提高了生產效率。這對於快速擴張的生物製藥產品線至關重要。隨著生物製藥產業持續主導藥物研發，製造商正加大對一次性流體處理系統的投資，以支持高產量、高品質的生產。例如，2025年2月，賽默飛世爾科技公司擴建了位於新加坡的生物製藥生產設施，以提高亞太地區生物製藥生產用預組裝一次性系統的產量。這增強了全球供給能力，以滿足日益成長的生物製藥需求。這也反映了主導對一次性組件的需求這一現實。

此外，對靈活模組化生產日益成長的需求正在改變製藥生產模式，進一步推動一次性組件市場的發展。製造商和合約研發生產機構（CDMO）正擴大轉向模組化設施，以實現快速安裝、多產品轉換和減少設施面積。一次性組件在這項轉型中發揮核心作用，它能夠實現生物製程線的即插即用配置，並消除批次間大規模的清洗驗證。這種柔軟性在產品種類繁多的契約製造環境中尤其重要。為了進一步支持這一趨勢，頗爾公司於2025年1月發布了一款模組化3D袋系統，該系統配備在線無菌連接器，專為上游工程培養基製備和大容量過濾設計。這有助於加快模組化設施的設定速度，並提高製程柔軟性。

此外，隨著細胞和基因療法生產的擴展，由於這些治療方法具有小批量生產、患者特異性和極其精細的特性，對一次性組件的需求顯著增加。 CAR-T療法、病毒載體和幹細胞產品需要密封無菌系統來防止污染並確保產品均一性，因此一次性組件在整個上游和下游工作流程中都至關重要。此外，雖然這些治療方法通常需要工藝客製化，但一次性系統能夠提供快速調整和規模化所需的柔軟性。為了滿足這一日益成長的需求，賽多利斯股份公司於2025年3月推出了一款整合感測器技術的可客製化一次性取樣組件，專門用於細胞療法的填充和表面處理工程。這有助於提高先進療法生產過程中的製程控制和無菌性。

因此，由於上述因素，預計一次性組件的整體市場在預測期內將擴大。

然而，一次性組件的廢棄特性會產生大量塑膠廢棄物，嚴重阻礙因素了市場成長。日益成長的環境問題和更嚴格的永續發展法規迫使製造商探索環保替代方案並改善廢棄物管理。此外，嚴格的產品核可流程也進一步限制了市場擴張。這是因為無論在哪個地區，一次性系統都必須經過萃取物、洗脫液、無菌性和材料相容性的全面檢驗。這些複雜且耗時的核准要求增加了研發成本，延緩了產品商業化進程，對生物製程產業的快速推廣應用構成了重大障礙。

一次組裝市場細分分析

一次性組件市場：依產品類型（袋式組件、過濾組件、瓶式組件、混合系統組件、管路及連接器組件）、按解決方案（標準及客製化）、按應用（上游工程、下游製程、儲存及運輸、過濾、灌裝及精加工/滅菌）、依材質（聚乙烯 (PE)、聚丙烯 (PP)、含聚氯乙烯(PVC)、含氯乙烯（PVC)、其他生物製藥公司及依碳化藥物公司、依氯乙烯（PVC） (CDMO)、其他）及按地區（北美、歐洲、亞太、世界其他地區）分類

一次組裝市場的區域分析

北美一次性組件市場趨勢

預計到2025年，北美將佔一次性組件市場最大的佔有率，達到所有地區的41%。北美預計將主導一次性組件市場，這得益於其高度發達的生物製藥生態系統、主要企業的強大影響力、先進的研發基礎設施以及對創新生物製程技術的早期應用。該地區，尤其是美國，擁有眾多大型生技藥品和疫苗生產商，以及許多合約研發生產機構（CDMO），這些機構高度依賴一次性系統來實現柔軟性、擴充性和無污染生產。此外，對生技藥品、細胞和基因治療以及個人化醫療領域投資的不斷增加，也進一步加速了向一次性模組化生產平台的轉變。

北美也受益於強大的法規結構，該框架支援先進的生物製程技術，以及為一次性組件（如袋子、管子、過濾器和連接器）建立的成熟供應鏈。

近期領先企業的一系列策略性舉措進一步鞏固了北美在該市場的主導地位。 2025年2月，賽默飛世爾科技公司宣布收購Solventum的純化和過濾業務，此舉旨在強化其生物製程產品組合，並拓展其在過濾技術領域的能力，而過濾技術是單次使用組裝系統的核心。 2025年4月，賽多利斯集團收購了MatTek公司和Visikol公司，增強了其在先進3D細胞模型方面的能力，從而更好地支持與單次使用生物製程需求密切相關的藥物發現和生物製藥開發流程。此外，北美持續進行大規模的基礎設施投資，例如賽默飛世爾科技公司在美國擴建單次使用技術生產設施，以滿足日益成長的生物製藥和先進治療方法需求。這些發展凸顯了北美在全球單次使用組裝市場的主導地位，領導企業正積極透過收購、產能擴張和技術進步來加強其在該地區的業務。

歐洲一次組裝市場的發展趨勢

在歐洲，由於該地區先進的生物製藥製造生態系統、生物製藥生產投資的不斷成長以及向靈活模組化生產設施的轉型，一次性組件市場正經歷強勁且持續的成長。歐洲，尤其是德國、瑞士、法國和英國，匯聚了許多領先的生物製藥公司和合約研發生產機構（CDMO），這些地區對一次性技術的應用正在迅速擴展。對單株抗體、疫苗以及細胞和基因療法等先進療法的需求不斷成長，進一步推動了對無污染、擴充性且經濟高效的生產解決方案的需求。一次性組件因其能夠減少清洗驗證要求、縮短生產週期並實現同一設施內多種產品的生產，而日益受到青睞，使其成為歐洲創新主導生物製藥行業的理想之選。此外，歐盟關於產品安全性和無菌性的嚴格法規也促使製造商採用密封的一次性系統，以確保合規性並降低污染風險。

領先企業近期採取的策略性舉措進一步凸顯了歐洲在該市場日益成長的重要性。 2025年6月，賽多利斯集團(Sartorius AGAG)擴大了其在歐洲的產能，以滿足市場對一次性生物製程系統日益成長的需求，從而加強了其面向生物製藥客戶的Flexsafe®袋、管和整合組件的供應鏈。此外，像龍沙(Lonza)這樣的歐洲合約研發生產機構(CDMO)正在加強一次性技術的整合，並擴展其生物製藥生產基礎設施，以支持複雜治療藥物的靈活生產。這些舉措反映了領先企業積極投資於擴大產能、升級技術和創新工藝，從而推動了歐洲在全球一次性組件市場中保持強勁且永續的成長勢頭。

亞太地區一次性組裝市場的發展趨勢

亞太地區正崛起為一次性組件市場的主要驅動力，這主要得益於生物製藥產能的快速擴張、醫療基礎設施投資的增加以及對生物製藥和生物相似藥生產的日益重視。中國、印度、韓國和日本等國家正經歷生物製造設施和合約研發生產機構（CDMO）建設的激增，這主要得益於成本優勢、政府支持以及龐大的患者群體。該地區也正成為全球製藥公司首選的外包目的地，進一步提升了對靈活、經濟高效且擴充性的生產解決方案（例如一次性組件）的需求。此外，模組化設施的日益普及以及細胞和基因治療產品線的成長，正在加速向一次性生物製程系統的轉變，這些系統能夠確保無菌性並降低操作複雜性。全球和區域公司持續投資以擴大產能和加強供應鏈，進一步鞏固了亞太地區作為一次性組件成長市場的地位。

一次性組裝市場的主要參與者有哪些？

以下是單次使用組裝市場的主要參與者。這些公司合計佔最大的市場佔有率，並引領產業趨勢。

Thermo Fisher Scientific Inc.
Sartorius AG（Sartorius AG）
Cytiva (Danaher Corporation)
Merck KGaA
Avantor, Inc.
康寧公司
Saint-Gobain Life Sciences
Repligen Corporation
Meissner Filtration Products, Inc.
Entegris, Inc.
Pall Corporation
Eppendorf SE
Getinge AB
PBS Biotech
KUHNER AG
Lonza Group AG
ABEC, Inc.
3M
Parker-Hannifin Corporation
Colder Products Company（CPC）
其他

競爭格局對一次性組裝市場有何影響？

一次性組件市場的競爭格局高度動態且集中度適中，其特點是少數全球領導者與眾多區域性和細分參與企業並存。賽默飛世爾科技公司 (Thermo Fisher Scientific Inc.)、賽多利斯公司 (Sartorius AG)、默克集團 (Merck KGaA) 和丹納赫公司 (Danaher Corporation) 等領先企業憑藉其豐富的產品系列、強大的全球分銷網路以及對研發的持續投入，主導著市場。這些公司專注於創新，尤其是在改進產品整合、提升材料性能以及支援自動化和模組化製造等先進生物製程技術方面。同時，市場仍保持一定程度的分散性，Avantor 公司、聖戈班集團 (Saint-Gobain) 和 Entegris 公司等專業公司透過提供細分市場組件和客製化解決方案，豐富了競爭格局。

隨著企業致力於鞏固市場地位並拓展全球企業發展，策略聯盟、夥伴關係關係、收購和產能擴張正在進一步重塑競爭格局。例如，生物製藥企業與一次性技術供應商之間的夥伴關係十分普遍，雙方共同開發針對特定上游和下游製程的客製化解決方案。此外，企業越來越重視客製化、永續性（例如，使用可回收材料）和數位整合，這些正逐漸成為市場競爭的關鍵差異化因素。

此外，監管合規和品質保證在塑造競爭格局中發揮著至關重要的作用。企業必須滿足萃取物、洗脫液和無菌性方面的嚴格標準，這為新進入者設定了很高的進入門檻。成熟企業受益於規模經濟和強大的供應商網路，而中小企業和新興企業透過提供創新且針對特定應用的解決方案來競爭。總體而言，競爭格局的特點是主要參與者之間的整合與大型企業和專業製造商持續創新之間的平衡，這支撐著一次性組件市場的持續成長和技術進步。

一次組裝市場的最新發展趨勢

2025 年 10 月，Avantor 公司（Avantor）宣布推出下一代無菌採樣平台和基於 PUPSIT 的預製過濾組件，旨在改善無菌加工環境中的污染控制，並符合歐盟 GMP 附件 1 的嚴格要求。
2025 年 6 月，賽多利斯股份公司擴大了在歐洲的生產能力，以滿足對一次性生物製程系統日益成長的需求，從而加強了其向生物製藥客戶提供 Flexsafe® 袋、管和整合組件的供應鏈。

一次組裝市場的市場細分

按產品接觸面積分類的一次性組件
袋子組件
過濾組件
瓶子組裝
混合系統組件
管路和連接器組件
暴露於溶液中的一次性組件
標準
客製化
透過應用程式一次組裝
上游工程
下游工藝
倉儲和運輸
過濾
填充和精加工/無菌處理
一次組裝材料的接觸
聚乙烯（PE）
聚丙烯（PP）
聚氯乙烯（PVC）
其他
最終用戶接觸一次性組件
生物製藥和生物技術公司
合約開發和製造組織
其他
一次性組件的區域趨勢
北美一次組裝市場
美國一次組裝市場
加拿大一次組裝市場
墨西哥一次組裝市場
歐洲一次組裝市場
英國一次組裝市場
德國一次組裝市場
法國一次組裝市場
義大利一次組裝市場
西班牙一次組裝市場
其他歐洲一次組裝市場
亞太一次性組裝市場
中國的一次組裝市場
日本一次性組件市場
印度的一次組裝市場
澳洲一次組裝市場
韓國一次組裝市場
亞太地區其他一次性組裝市場
其他地區的單次使用組裝市場
南美洲一次組裝市場
中東一次組裝市場
非洲一次組裝市場

影響分析

人工智慧驅動的創新與應用：

人工智慧驅動的創新正日益改變一次性組件市場，提升生物製藥生產的效率、可靠性和擴充性。人工智慧，特別是機器學習和進階數據分析，正被整合到一次性系統中，實現預測性維護、即時監控和製程最佳化。例如，整合到一次性組件中的人工智慧感測器可以持續追蹤壓力、過濾和流速等參數，從而及早發現異常情況，降低批次失敗的風險。在實際應用中，人工智慧透過最佳化上游和下游工藝（包括細胞培養監控、過濾和流體處理），支持智慧生物製程，從而提高生物製藥生產的產量和一致性。

此外，透過利用人工智慧驅動的數位雙胞胎和模擬模型在虛擬環境中設計和測試一次性元件，可以最大限度地縮短開發時間和降低成本。這些技術還能確保資料完整性和可追溯性，進而促進自動化品管和法規遵循。人工智慧還能對一次性組件進行需求預測和供應鏈最佳化，幫助製造商維持庫存效率並快速回應生產需求的波動。總而言之，人工智慧與一次性組件的整合正在推動生物製造生態系統向更智慧、自動化和柔軟性的方向轉型。

美國關稅對一次性組裝市場的影響分析：

美國關稅環境對一次性組件（SUA）市場產生了多方面且顯著的影響，主要體現在成本上升、全球供應鏈中斷以及製造策略結構性變革加速等方面。一次性組件廣泛應用於生物製藥生產，其生產嚴重依賴進口原料，例如來自歐洲和亞洲的聚合物（聚丙烯、矽膠、聚氯乙烯等）和特殊零件。基本進口關稅（許多商品的關稅約為10%），以及某些情況下對藥品及相關原料徵收的更高關稅，直接推高了一次性組件製造商的物料清單（BoM）成本和總生產成本。

此外，關稅導致供應鏈效率低下，包括前置作業時間和物流成本增加，這些問題在即時生物製造環境中尤其嚴重。企業面臨著許多營運挑戰，例如重新認證替代供應商、監管合規負擔以及因籌資策略調整而導致的生產計劃延誤。此外，近90%的美國生技公司至少一半的產品依賴進口組件，這進一步加劇了關稅政策對整個生命科學生態系統的成本影響。

從戰略角度來看，隨著企業尋求降低進口關稅和緩解地緣政治風險，這些關稅正在推動製造業向美國本土轉移和本地化。然而，這項轉型受到許多因素的限制，包括需要大量資本投資、國內高品質一次性組件的生產能力有限以及嚴格的監管驗證流程。同時，關稅也影響產品設計和籌資策略，企業越來越傾向於採用標準化組件而非客製化解決方案，以簡化採購流程並降低成本。總體而言，儘管美國關稅旨在加強國內製造業，但同時也造成了短期成本壓力、營運複雜性增加，並延緩了一次性組件和組裝市場採用靈活生物製程解決方案的進程。

這項分析能為客戶帶來哪些好處？

成本管理：透過了解關稅趨勢，客戶可以預測成本上漲，並據此調整定價策略，以確保盈利。
供應鏈最佳化：透過尋找替代來源並使其供應鏈多元化，客戶可以減少對高關稅地區的依賴，增強自身抵禦能力。
監管合規：專家指導幫助客戶應對不斷變化的法規環境，從而保持合規並避免潛在的法律挑戰。
策略規劃：深入了解關稅的影響，使客戶能夠就製造地、夥伴關係和打入市場策略做出明智的決策。

一次性組件市場報告要點。

一次性組件市場目前規模分析（2025 年）及 8 年市場預測（2026 年至 2034 年）
過去三年發生的主要產品和技術開發、併購、夥伴關係和合資企業
主導一次性組裝市場的領導公司。
一次性組裝市場的其他競爭者也面臨各種機會。
哪些細分市場在 2025 年表現最佳？這些細分市場在 2034 年的表現又會如何？
目前哪些地區、國家在一次性組裝市場表現最佳？
企業應專注於哪些地區和國家，以尋求一次性組裝市場的未來成長機會？

關於一次性組件市場的常見問題

1. 一次性組裝市場的成長率是多少？

預計從 2026 年到 2034 年的預測期內，一次性組裝市場將以 15.05% 的複合年成長率成長。

2. 一次性組件的市場是什麼？

全球一次性組裝市場預計將從 2025 年的 137.6295 億美元成長到 2034 年的 481.7343 億美元。

3. 哪個地區在一次性組裝市場中佔最大的市佔率？

由於北美地區擁有許多大型生物製藥企業、先進的生物製藥生產基礎設施，以及一次性技術在商業和臨床規模生產中的高普及率，預計該地區將主導一次性組裝市場。此外，該地區在細胞和基因治療、疫苗研發以及單株抗體生產方面的大量投資也為其發展提供了助力，這些領域高度依賴靈活且無污染的生物製程系統。同時，賽默飛世爾科技公司、Cytiva公司和默克公司等主要市場參與企業的強大影響力，以及完善的合約研發生產（CDMO）生態系統和支持性的法規結構，進一步鞏固了北美在該市場的領先地位。

4. 一次性組裝市場的成長要素為何？

生物製劑和生物製藥的快速成長、對靈活模組化生產日益成長的需求，以及細胞和基因治療生產的擴張，共同推動了生物製程產業對一次性組件的加速應用。隨著生物製劑產品線的擴展，製造商需要擴充性、無污染且經濟高效的生產系統，而一次性組件恰好能夠滿足這些需求。同時，模組化設施的普及使得設備搭建更加快捷，能夠實現多產品生產，並降低操作複雜性，進一步增強了對一次性系統的依賴。此外，細胞和基因治療的複雜性和小批量生產的特點，要求高度可控的密封系統環境，而一次性組件在確保無菌、降低交叉污染風險以及支持快速製程開發方面發揮著至關重要的作用。這些趨勢共同推動了市場強勁且永續的成長。

5. 一次性組裝市場的主要企業有哪些？

在一次性組件市場中運作的主要市場參與企業包括 Thermo Fisher Scientific Inc.、Sartorius、Cytiva（丹納赫公司）、Merck KGaA、Avantor, Inc.、Corning Incorporated、Saint-Gobain Life Sciences、Repligen Corporation、Meissner Filtration Bior.、Integris、Petal Corporation, Integid. AG、ABEC, Inc.、3M、Parker-Hannifin Corporation 和 Colder Products Company (CPC)。

依產品
- 袋子組件
- 過濾裝置
- 瓶子組裝
- 混合系統組件
- 管和連接器組件
透過解決方案
- 標準
- 客製化
用途別
- 上游工程
- 下游工藝
- 倉儲和運輸
- 濾
- 填充和精加工/無菌處理
材質
- 聚乙烯（PE）
- 聚丙烯（PP）
- 聚氯乙烯（PVC）
- 其他
最終用戶
- 生物製藥和生物技術公司
- 合約開發和製造組織
按地區
- 北美洲
- 歐洲
- 亞太地區
- 其他地區

第8章競爭情勢

第9章：創業資金籌措與投資趨勢

第10章：一次性組裝市場－公司與產品概況

Thermo Fisher Scientific Inc.
Sartorius AG
Cytiva (Danaher Corporation)
Merck KGaA
Avantor, Inc.
Corning Incorporated
Saint-Gobain Life Sciences
Repligen Corporation
Meissner Filtration Products, Inc.
Entegris, Inc.
Pall Corporation
Eppendorf SE
Getinge AB
PBS Biotech
KUHNER AG
Lonza Group AG
ABEC, Inc.
3M
Parker-Hannifin Corporation
Colder Products Company (CPC)

第11章：KOL的觀點

第12章專案方法

第13章：關於 DelveInsight

第14章免責聲明與聯絡方式

簡介目錄圖表

Product Code: DIMDCL0912

Single-use Assemblies Market Summary

The global single-use assemblies market is expected to increase from USD 13,762.95 million in 2025 to USD 48,173.43 million by 2034, reflecting strong and sustained growth.
The global single-use assemblies market is growing at a CAGR of 15.05% during the forecast period from 2026 to 2034.
The rapid growth of biologics and biopharmaceuticals, rising demand for flexible and modular manufacturing, and the expansion of cell and gene therapy production are collectively accelerating the adoption of single-use assemblies across the bioprocessing industry. As biologic pipelines expand, manufacturers require scalable, contamination-free, and cost-efficient production systems, which single-use assemblies readily provide. At the same time, the shift toward modular facilities enables faster setup, multi-product manufacturing, and reduced operational complexity, further increasing reliance on disposable systems. Additionally, the complex and small-batch nature of cell and gene therapies demands highly controlled, closed-system environments, where single-use assemblies play a critical role in ensuring sterility, reducing cross-contamination risk, and supporting rapid process development. Together, these trends are driving strong and sustained market growth.
The leading companies operating in the single-use assemblies market include Thermo Fisher Scientific Inc., Sartorius AG, Cytiva (Danaher Corporation), Merck KGaA, Avantor, Inc., Corning Incorporated, Saint-Gobain Life Sciences, Repligen Corporation, Meissner Filtration Products, Inc., Entegris, Inc., Pall Corporation, Eppendorf SE, Getinge AB, PBS Biotech, KUHNER AG, Lonza Group AG, ABEC, Inc., 3M, Parker-Hannifin Corporation, Colder Products Company (CPC), and others.
North America is expected to dominate the single-use assemblies market due to the strong presence of leading biopharmaceutical manufacturers, advanced biologics production infrastructure, and high adoption of single-use technologies in both commercial and clinical-scale manufacturing. The region also benefits from significant investments in cell and gene therapy, vaccine development, and monoclonal antibody production, which heavily rely on flexible and contamination-free bioprocessing systems. Additionally, the strong presence of key market players such as Thermo Fisher Scientific, Cytiva, and Merck, along with a well-established CDMO ecosystem and supportive regulatory framework, further strengthens North America's leadership in this market.
In the product segment of the single-use assemblies market, the filtration assemblies category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Single-use Assemblies Market

Rapid growth of biologics & biopharmaceuticals leading to a surge in single-use assemblies: The expansion of biologics such as monoclonal antibodies, recombinant proteins, vaccines, and biosimilars is the primary driver of single-use assemblies. These therapies require flexible, scalable, and contamination-controlled manufacturing systems, which single-use technologies provide. Increasing global demand for biologic drugs is accelerating adoption across both commercial manufacturing and clinical production.
Rising demand for flexible & modular manufacturing: Pharmaceutical companies and CDMOs are increasingly transitioning from large, fixed stainless-steel manufacturing plants toward modular and flexible production facilities. In this shift, single-use assemblies play a key role by enabling rapid changeover between production batches, allowing multiple products to be manufactured within the same facility, and significantly reducing overall facility footprint and infrastructure complexity. This flexibility is particularly critical for small-batch biologics and personalized medicine manufacturing, where production needs to be agile, scalable, and responsive to highly specific patient or product demands.
Expansion of cell and gene therapy manufacturing: Cell therapy, gene therapy, and regenerative medicine require highly specialized manufacturing conditions characterized by small-scale, tightly controlled environments, closed and sterile processing systems, and the ability to manage significant product variability. Single-use assemblies are well-suited to meet these demands as they help maintain sterility, reduce contamination risks, and provide the flexibility needed for complex and patient-specific processes. As a result, they have become essential components in advanced biomanufacturing workflows, including CAR-T cell therapy, viral vector production, and stem cell manufacturing.

Single-use Assemblies Market Report Segmentation

This single-use assemblies market report offers a comprehensive overview of the global single-use assemblies market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product (Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, and Tubing & Connector Assemblies), Solution (Standard and Customized), Application (Upstream Processing, Downstream Processing, Filteration, Sampling & Fluid Handling, and Fill-Finish/Aseptic Processing), Material Type (Polyethylene (PE), Polypropylene (PP), Polyvinyl chloride (PVC), and Others), End-Users (Biopharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing single-use assemblies market.

Single-use assemblies are pre-sterilized, disposable systems of interconnected components (such as bags, tubing, filters, and connectors) used in biopharmaceutical manufacturing for fluid handling, processing, and storage, which are discarded after one use to reduce contamination risk and improve operational flexibility.

The rapid growth of biologics and biopharmaceuticals, combined with the increasing demand for flexible and modular manufacturing solutions, is significantly accelerating the adoption of single-use assemblies across the bioprocessing industry. As biologic drug pipelines continue to expand in both scale and complexity, manufacturers are under growing pressure to implement scalable, contamination-free, and cost-efficient production systems that can adapt quickly to changing production needs. Single-use assemblies address these requirements by eliminating the need for extensive cleaning and sterilization processes while also reducing downtime between batches.

At the same time, the industry-wide shift toward modular and multi-product manufacturing facilities is further strengthening their adoption. These facilities benefit from faster installation, simplified validation, and the ability to switch between different products with minimal operational disruption, making disposable systems highly advantageous for modern biomanufacturing setups. In parallel, the rapid expansion of cell and gene therapy production, characterized by small-batch, high-value, and highly personalized treatments, has increased the need for closed, highly controlled processing environments. Single-use assemblies are particularly well-suited for these applications as they ensure sterility, minimize the risk of cross-contamination, and support faster process development and scale-up. Collectively, these factors are driving robust and sustained growth in the global single-use assemblies market.

What are the latest single-use assemblies market dynamics and trends?

Rapid growth of biologics & biopharmaceuticals is a major driver accelerating the adoption of single-use assemblies, as these therapies, such as monoclonal antibodies, vaccines, and recombinant proteins, require highly sterile, scalable, and contamination-free manufacturing environments. Single-use systems eliminate cleaning and validation steps, significantly reducing downtime and improving production efficiency, which is critical for fast-growing biologics pipelines. As biologics continue to dominate drug development, manufacturers are increasingly investing in disposable fluid handling systems to support high-volume and high-quality production. For instance, in February 2025, Thermo Fisher Scientific expanded its bioproduction facility in Singapore to scale production of pre-assembled single-use systems for biologics manufacturing in the Asia-Pacific region, strengthening global supply capabilities and meeting rising biologics demand. This reflects how leading players are directly expanding capacity to support biologics-driven demand for single-use assemblies.

Additionally, the rising demand for flexible and modular manufacturing is reshaping pharmaceutical production models, further boosting the single-use assemblies market. Manufacturers and CDMOs are increasingly shifting toward modular facilities that enable rapid installation, multi-product switching, and reduced facility footprint. Single-use assemblies are central to this transformation because they allow plug-and-play configuration of bioprocessing lines and eliminate the need for extensive cleaning validation between batches. This flexibility is particularly valuable in contract manufacturing environments where product diversity is high. Supporting this trend, in January 2025, Pall Corporation introduced a modular 3D bag system with in-line sterile connectors designed for upstream media preparation and high-volume filtration, enabling faster setup and improved process flexibility in modular facilities.

Furthermore, the expansion of cell and gene therapy manufacturing is significantly increasing the need for single-use assemblies due to the small-batch, patient-specific, and highly sensitive nature of these therapies. CAR-T therapies, viral vectors, and stem cell products require closed, sterile systems to prevent contamination and ensure product consistency, making disposable assemblies essential across upstream and downstream workflows. These therapies also involve frequent process customization, where single-use systems offer the flexibility needed for rapid adaptation and scale-up. Reflecting this growing demand, in March 2025, Sartorius launched a customizable single-use sampling assembly with integrated sensor technology specifically targeting cell therapy fill-finish operations, improving process control and sterility in advanced therapy manufacturing.

Thus, the factors mentioned above are expected to boost the overall market of single-use assemblies during the forecast period.

However, the high plastic waste generation due to the disposable nature of single-use assemblies acts as a key limiting factor for market growth, as increasing environmental concerns and stricter sustainability regulations are pushing manufacturers to seek eco-friendly alternatives and improve waste management practices. Additionally, the stringent regulatory process for product approval further restricts market expansion, as single-use systems must undergo extensive validation for extractables, leachables, sterility, and material compatibility across different regions. These complex and time-consuming approval requirements increase development costs and delay product commercialization, thereby acting as a significant barrier to faster adoption in the bioprocessing industry.

Single-use Assemblies Market Segment Analysis

Single-use Assemblies Market by Product (Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, and Tubing & Connector Assemblies), Solution (Standard and Customized), Application (Upstream Processing, Downstream Processing, Storage & Transport, Filteration, and Fill-Finish/Aseptic Processing), Material Type (Polyethylene (PE), Polypropylene (PP), Polyvinyl chloride (PVC), and Others), End-Users (Biopharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Single-use Assemblies Market Regional Analysis

North America Single-use Assemblies Market Trends

North America is expected to account for the highest proportion of 41% of the Single-use Assemblies market in 2025, out of all regions. North America is expected to dominate the single-use assemblies market due to its highly developed biopharmaceutical ecosystem, strong presence of leading life science companies, advanced R&D infrastructure, and early adoption of innovative bioprocessing technologies. The region, particularly the United States, hosts a large number of major biologics and vaccine manufacturers as well as contract development and manufacturing organizations (CDMOs), which heavily rely on single-use systems for flexible, scalable, and contamination-free production. In addition, rising investments in biologics, cell and gene therapies, and personalized medicine are further accelerating the shift toward disposable and modular manufacturing platforms.

North America also benefits from strong regulatory frameworks that support advanced bioprocessing technologies, along with well-established supply chains for single-use components such as bags, tubing, filters, and connectors.

Recent strategic developments by key players further reinforce North America's dominance in this market. In February 2025, Thermo Fisher Scientific announced the acquisition of Solventum's Purification and Filtration business, a move designed to strengthen its bioprocessing portfolio and expand its capabilities in filtration technologies, which are central to single-use assembly systems. In April 2025, Sartorius AG acquired MatTek Corp and Visikol Inc., enhancing its capabilities in advanced 3D cell models that support drug discovery and biologics development workflows closely linked to single-use bioprocessing demand. Additionally, North America continues to witness large-scale infrastructure investments, such as Thermo Fisher's expansion of single-use technology manufacturing facilities in the United States, aimed at meeting the growing demand for biologics and advanced therapies. These developments highlight how leading companies are actively strengthening their presence in the region through acquisitions, capacity expansions, and technology advancements, thereby reinforcing North America's leadership position in the global single-use assemblies market.

Europe Single-use Assemblies Market Trend

The single-use assemblies market in Europe is witnessing strong and sustained growth, driven by the region's advanced biopharmaceutical manufacturing ecosystem, increasing investment in biologics production, and the growing shift toward flexible and modular manufacturing facilities. Europe is home to a large number of leading pharmaceutical companies and contract development and manufacturing organizations (CDMOs), particularly in countries such as Germany, Switzerland, France, and the United Kingdom, where adoption of single-use technologies is accelerating rapidly. The rising demand for monoclonal antibodies, vaccines, and advanced therapies such as cell and gene therapies is further boosting the need for contamination-free, scalable, and cost-efficient manufacturing solutions. Single-use assemblies are increasingly preferred because they reduce cleaning validation requirements, shorten production cycles, and support multi-product manufacturing within the same facility, making them highly suitable for Europe's innovation-driven biopharma sector. In addition, stringent EU regulatory standards related to product safety and sterility are encouraging manufacturers to adopt closed, single-use systems to ensure compliance and reduce contamination risks.

Recent strategic developments by key companies further highlight Europe's growing importance in this market. In June 2025, Sartorius AG expanded its production capacity across Europe to support increasing demand for single-use bioprocessing systems, strengthening its ability to supply Flexsafe(R) bags, tubing, and integrated assemblies to biopharmaceutical customers. Additionally, European CDMOs such as Lonza have been enhancing their biologics manufacturing infrastructure with increased integration of disposable technologies to support flexible production of complex therapies. These developments reflect how leading companies are actively investing in capacity expansion, technology upgrades, and process innovation within Europe, reinforcing the region's strong and sustained growth trajectory in the global single-use assemblies market.

Asia-Pacific Single-use Assemblies Market Trends

The Asia Pacific (APAC) region is emerging as a major growth driver for the single-use assemblies market due to the rapid expansion of its biopharmaceutical manufacturing capabilities, increasing investments in healthcare infrastructure, and growing focus on biologics and biosimilars production. Countries such as China, India, South Korea, and Japan are witnessing a surge in the establishment of new biomanufacturing facilities and CDMOs, driven by cost advantages, supportive government initiatives, and a large patient population. The region is also becoming a preferred outsourcing destination for global pharmaceutical companies, further increasing the demand for flexible, cost-effective, and scalable manufacturing solutions such as single-use assemblies. Additionally, the rising adoption of modular facilities, coupled with the growing pipeline of cell and gene therapies, is accelerating the shift toward disposable bioprocessing systems that ensure sterility and reduce operational complexity. Continuous investments by both global and regional players in expanding production capacity and strengthening supply chains are further reinforcing APAC's position as a high-growth market for single-use assemblies.

Who are the major players in the single-use assemblies market?

The following are the leading companies in the single-use assemblies market. These companies collectively hold the largest market share and dictate industry trends.

Thermo Fisher Scientific Inc.
Sartorius AG
Cytiva (Danaher Corporation)
Merck KGaA
Avantor, Inc.
Corning Incorporated
Saint-Gobain Life Sciences
Repligen Corporation
Meissner Filtration Products, Inc.
Entegris, Inc.
Pall Corporation
Eppendorf SE
Getinge AB
PBS Biotech
KUHNER AG
Lonza Group AG
ABEC, Inc.
3M
Parker-Hannifin Corporation
Colder Products Company (CPC)
Others

How is the competitive landscape shaping the single-use assemblies market?

The competitive landscape of the single-use assemblies market is highly dynamic and moderately concentrated, characterized by the presence of a few global leaders alongside numerous regional and niche players. Major companies such as Thermo Fisher Scientific, Sartorius AG, Merck KGaA, and Danaher Corporation dominate the market due to their extensive product portfolios, strong global distribution networks, and continuous investments in research and development. These players focus heavily on innovation, particularly in enhancing product integration, improving material performance, and supporting advanced bioprocessing technologies such as automation and modular manufacturing. At the same time, the market remains fragmented to some extent, with several specialized companies like Avantor, Saint-Gobain, and Entegris offering niche components and customized solutions, contributing to competitive diversity.

Competition is further shaped by strategic collaborations, partnerships, acquisitions, and capacity expansions, as companies aim to strengthen their market position and expand their global footprint. For instance, partnerships between biopharmaceutical manufacturers and single-use technology providers are common to co-develop tailored solutions for specific upstream and downstream processes. Additionally, companies are increasingly focusing on customization, sustainability (e.g., recyclable materials), and digital integration, which are emerging as key differentiators in the market.

Moreover, regulatory compliance and quality assurance play a critical role in shaping competition, as companies must meet stringent standards related to extractables, leachables, and sterility, which creates high entry barriers for new players. While established firms benefit from economies of scale and strong supplier networks, smaller and emerging players compete by offering innovative, application-specific solutions. Overall, the competitive landscape is defined by a balance of consolidation among major players and continuous innovation driven by both large corporations and specialized manufacturers, supporting sustained growth and technological advancement in the single-use assemblies market.

Recent Developmental Activities in the Single-use Assemblies Market

In October 2025, Avantor introduced next-generation sterile sampling platforms and pre-engineered PUPSIT-based filtration assemblies, designed to improve contamination control and compliance with stringent EU GMP Annex 1 requirements in aseptic processing environments.
In June 2025, Sartorius AG expanded its production capacity across Europe to support increasing demand for single-use bioprocessing systems, strengthening its ability to supply Flexsafe(R) bags, tubing, and integrated assemblies to biopharmaceutical customers.

Single-use Assemblies Market Segmentation

Single-use Assemblies by Product Exposure
Bag Assemblies
Filtration Assemblies
Bottle Assemblies
Mixing System Assemblies
Tubing & Connector Assemblies
Single-use Assemblies by Solution Exposure
Standard
Customized
Single-use Assemblies Application Exposure
Upstream Processing
Downstream Processing
Storage & Transport
Filteration
Fill-Finish/Aseptic Processing
Single-use Assemblies Material Type Exposure
Polyethylene (PE)
Polypropylene (PP)
Polyvinyl chloride (PVC)
Others
Single-use Assemblies End-Users Exposure
Biopharmaceutical & Biotechnology Companies
Contract Development & Manufacturing Organizations
Others
Single-use Assemblies Geography Exposure
North America Single-use Assemblies Market
United States Single-use Assemblies Market
Canada Single-use Assemblies Market
Mexico Single-use Assemblies Market
Europe Single-use Assemblies Market
United Kingdom Single-use Assemblies Market
Germany Single-use Assemblies Market
France Single-use Assemblies Market
Italy Single-use Assemblies Market
Spain Single-use Assemblies Market
Rest of Europe Single-use Assemblies Market
Asia-Pacific Single-use Assemblies Market
China Single-use Assemblies Market
Japan Single-use Assemblies Market
India Single-use Assemblies Market
Australia Single-use Assemblies Market
South Korea Single-use Assemblies Market
Rest of Asia-Pacific Single-use Assemblies Market
Rest of the World Single-use Assemblies Market
South America Single-use Assemblies Market
Middle East Single-use Assemblies Market
Africa Single-use Assemblies Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are increasingly transforming the single-use assemblies market by enhancing efficiency, reliability, and scalability across biopharmaceutical manufacturing. Artificial intelligence, particularly machine learning and advanced data analytics, is being integrated into single-use systems to enable predictive maintenance, real-time monitoring, and process optimization. For instance, AI-driven sensors embedded within single-use assemblies can continuously track parameters such as pressure, temperature, and flow rates, allowing early detection of anomalies and reducing the risk of batch failure. In applications, AI supports smart bioprocessing by optimizing upstream and downstream operations, including cell culture monitoring, filtration, and fluid handling, thereby improving yield and consistency in biologics production.

Additionally, AI-powered digital twins and simulation models are used to design and test single-use assemblies virtually, minimizing development time and costs. These technologies also facilitate automated quality control and regulatory compliance by ensuring data integrity and traceability. Furthermore, AI enables demand forecasting and supply chain optimization for single-use components, helping manufacturers maintain inventory efficiency and respond quickly to fluctuations in production needs. Overall, the integration of AI in single-use assemblies is driving a shift toward more intelligent, automated, and flexible biomanufacturing ecosystems.

U.S. Tariff Impact Analysis on Single-use Assemblies Market:

The U.S. tariff environment has had a significant and multi-layered impact on the single-use assemblies (SUA) market, primarily by increasing costs, disrupting global supply chains, and accelerating structural shifts in manufacturing strategies. Single-use assemblies widely used in biopharmaceutical production are heavily dependent on imported raw materials such as polymers (e.g., polypropylene, silicone, and PVC) and specialized components sourced from Europe and Asia. The imposition of tariffs, including baseline import duties (around 10% on many goods) and, in some cases, much higher tariffs on pharmaceuticals and related inputs, has directly increased the bill of materials (BoM) and overall production costs for SUA manufacturers.

Moreover, tariffs have introduced supply chain inefficiencies, including supplier disruptions, longer lead times, and increased logistics costs, which are particularly critical in a just-in-time biomanufacturing environment. Companies are facing operational challenges such as requalification of alternative suppliers, regulatory compliance burdens, and delays in production timelines when switching sourcing strategies. Additionally, nearly 90% of U.S. biotech firms rely on imported components for at least half of their products, amplifying the cost sensitivity of tariff policies on the broader life sciences ecosystem.

From a strategic perspective, these tariffs are driving a shift toward reshoring and localization of manufacturing within the United States, as companies seek to mitigate import duties and reduce geopolitical risks. However, this transition is constrained by high capital investment requirements, limited domestic manufacturing capacity for high-quality single-use components, and stringent regulatory validation processes. At the same time, tariffs are influencing product design and procurement strategies, with a growing preference for standardized assemblies over customized solutions to simplify sourcing and reduce costs. Overall, while U.S. tariffs aim to strengthen domestic manufacturing, they are simultaneously creating short-term cost pressures, operational complexity, and slower adoption of flexible bioprocessing solutions in the single-use assemblies market.

How This Analysis Helps Clients

Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the single-use assemblies market report study

Market size analysis for the current single-use assemblies market size (2025), and market forecast for 8 years (2026 to 2034)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the single-use assemblies market.
Various opportunities available for the other competitors in the single-use assemblies market space.
What are the top-performing segments in 2025? How these segments will perform in 2034?
Which are the top-performing regions and countries in the current single-use assemblies market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for the single-use assemblies market growth in the future.

Frequently Asked Questions for the Single-use Assemblies Market

1. What is the growth rate of the single-use assemblies market?

The single-use assemblies market is estimated to grow at a CAGR of 15.05% during the forecast period from 2026 to 2034.

2. What is the market for single-use assemblies?

The global single-use assemblies market is expected to increase from USD 13,762.95 million in 2025 to USD 48,173.43 million by 2034.

3. Which region has the highest share in the single-use assemblies market?

North America is expected to dominate the single-use assemblies market due to the strong presence of leading biopharmaceutical manufacturers, advanced biologics production infrastructure, and high adoption of single-use technologies in both commercial and clinical-scale manufacturing. The region also benefits from significant investments in cell and gene therapy, vaccine development, and monoclonal antibody production, which heavily rely on flexible and contamination-free bioprocessing systems. Additionally, the strong presence of key market players such as Thermo Fisher Scientific, Cytiva, and Merck, along with a well-established CDMO ecosystem and supportive regulatory framework, further strengthens North America's leadership in this market.

4. What are the drivers for the single-use assemblies market?

The rapid growth of biologics and biopharmaceuticals, rising demand for flexible and modular manufacturing, and the expansion of cell and gene therapy production are collectively accelerating the adoption of single-use assemblies across the bioprocessing industry. As biologic pipelines expand, manufacturers require scalable, contamination-free, and cost-efficient production systems, which single-use assemblies readily provide. At the same time, the shift toward modular facilities enables faster setup, multi-product manufacturing, and reduced operational complexity, further increasing reliance on disposable systems. Additionally, the complex and small-batch nature of cell and gene therapies demands highly controlled, closed-system environments, where single-use assemblies play a critical role in ensuring sterility, reducing cross-contamination risk, and supporting rapid process development. Together, these trends are driving strong and sustained market growth.

5. Who are the key players operating in the single-use assemblies market?

Some of the key market players operating in the single-use assemblies market include Thermo Fisher Scientific Inc., Sartorius AG, Cytiva (Danaher Corporation), Merck KGaA, Avantor, Inc., Corning Incorporated, Saint-Gobain Life Sciences, Repligen Corporation, Meissner Filtration Products, Inc., Entegris, Inc., Pall Corporation, Eppendorf SE, Getinge AB, PBS Biotech, KUHNER AG, Lonza Group AG, ABEC, Inc., 3M, Parker-Hannifin Corporation, Colder Products Company (CPC), and others.

1. Single-use Assemblies Market Report Introduction

1.1 Scope of the Study
1.2 Market Segmentation
1.3 Market Assumption

2. Single-use Assemblies Market Executive Summary

2.1 Market at Glance

3. Single-use Assemblies Market Key Factors Analysis

3.1 Single-use Assemblies Market Drivers
- 3.1.1 Rapid growth of biologics & biopharmaceuticals
- 3.1.2 Rising demand for flexible & modular manufacturing
- 3.1.3 Expansion of cell and gene therapy manufacturing
3.2 Single-use Assemblies Market Restraints and Challenges
- 3.2.1 High plastic waste generation due to the disposable nature
- 3.2.2 Stringent regulatory process for product approval
3.3 Single-use Assemblies Market Opportunity
- 3.3.1 Sustainability & eco-friendly single-use solutions, such as recyclable materials and biodegradable materials

4. Impact Analysis

4.1 AI-Powered Innovations and Applications
4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

5.1 The United States
5.2 Europe
5.3 Japan
5.4 China

6. Single-use Assemblies Market Porter's Five Forces Analysis

6.1 Bargaining Power of Suppliers
6.2 Bargaining Power of Consumers
6.3 Threat of New Entrants
6.4 Threat of Substitutes
6.5 Competitive Rivalry

7. Single-use Assemblies Market Assessment

7.1 By Product
- 7.1.1 Bag Assemblies
- 7.1.2 Filtration Assemblies
- 7.1.3 Bottle Assemblies
- 7.1.4 Mixing System Assemblies
- 7.1.5 Tubing & Connector Assemblies
7.2 By Solution
- 7.2.1 Standard
- 7.2.2 Customized
7.3 By Application
- 7.3.1 Upstream Processing
- 7.3.2 Downstream Processing
- 7.3.3 Storage & Transport
- 7.3.4 Filteration
- 7.3.5 Fill-Finish/Aseptic Processing
7.4 By Material Type
- 7.4.1 Polyethylene (PE)
- 7.4.2 Polypropylene (PP)
- 7.4.3 Polyvinyl chloride (PVC)
- 7.4.4 Others
7.5 By End-Users
- 7.5.1 Biopharmaceutical & Biotechnology Companies
- 7.5.2 Contract Development & Manufacturing Organizations
- 7.5.3 Others
7.6 By Geography
- 7.6.1 North America
  - 7.6.1.1 United States Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.1.2 Canada Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.1.3 Mexico Single-use Assemblies Market Size in USD million (2023-2034)
- 7.6.2 Europe
  - 7.6.2.1 France Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.2.2 Germany Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.2.3 United Kingdom Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.2.4 Italy Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.2.5 Spain Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.2.6 Rest of Europe Single-use Assemblies Market Size in USD million (2023-2034)
- 7.6.3 Asia-Pacific
  - 7.6.3.1 China Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.3.2 Japan Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.3.3 India Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.3.4 Australia Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.3.5 South Korea Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.3.6 Rest of Asia-Pacific Single-use Assemblies Market Size in USD million (2023-2034)
- 7.6.4 Rest of the World (RoW)
  - 7.6.4.1 Middle East Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.4.2 Africa Single-use Assemblies Market Size in USD million (2023-2034)
  - 7.6.4.3 South America Single-use Assemblies Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Single-use Assemblies Market Company and Product Profiles

10.1 Thermo Fisher Scientific Inc.
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
10.2 Sartorius AG
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
10.3 Cytiva (Danaher Corporation)
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
10.4 Merck KGaA
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
10.5 Avantor, Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
10.6 Corning Incorporated
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
10.7 Saint-Gobain Life Sciences
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
10.8 Repligen Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
10.9 Meissner Filtration Products, Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
10.10 Entegris, Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
10.11 Pall Corporation
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
10.12 Eppendorf SE
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
10.13 Getinge AB
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
10.14 PBS Biotech
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
10.15 KUHNER AG
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
10.16 Lonza Group AG
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
10.17 ABEC, Inc.
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
10.18 3M
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
10.19 Parker-Hannifin Corporation
- 10.19.1 Company Overview
- 10.19.2 Company Snapshot
- 10.19.3 Financial Overview
- 10.19.4 Product Listing
- 10.19.5 Entropy
10.20 Colder Products Company (CPC)
- 10.20.1 Company Overview
- 10.20.2 Company Snapshot
- 10.20.3 Financial Overview
- 10.20.4 Product Listing
- 10.20.5 Entropy